![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
X
20
Gmfc Labs Pvt Ltd. Hyderabad In, based in India, is a pharmaceutical company.
One of their significant offerings is Flurbiprofen, supported by a 'Valid' Certificate of Suitability (CEP) with the number CEP 2022-065 - Rev 01
This Chemical Type CEP, issued on June 05, 2024, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 1519 associated with this CEP further emphasizes